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Abstract
Purpose Psychological distress after laryngeal cancer treat-
ment is prevalent. Although voice rehabilitation has shown
to improve functional outcomes and positively affect health-
related quality of life, to date, there has been limited study of
the associated effect of behavioural voice intervention on psy-
chological well-being/distress post laryngeal cancer.
Method Sixty-three patients with Tis-T4 laryngeal cancer
treated with (chemo)radiotherapy were prospectively recruit-
ed and randomised to either a voice rehabilitation (VR, n = 31)
or control group (n = 32). The VR group received 10 speech
pathology sessions consisting of both direct and indirect voice
intervention post (chemo)radiotherapy. The control group re-
ceived general voice education but not specific intervention.
As part of a multidisciplinary assessment battery, psycholog-
ical well-being/distress was measured using the Hospital
Anxiety and Depression Scale (HADS) pre, six and 12months
post VR.
Results Within-group analysis revealed a significant (p = 0.03)
reduction in the proportion of patients with anxiety in the VR
group between baseline and 12 months. No change over time
was observed in controls. Between-group analysis revealed a
trend for fewer VR cases demonstrating anxiety (p = 0.06) or
depression (p = 0.08) at 6 months and significantly fewer
demonstrating anxiety (p = 0.04) and depression (p = 0.04) at
12 months, compared to controls. Significant correlations were
observed between patients’ voice perceptions and reduced anxi-
ety (rpb = −0.38) and depression (rpb = −0.66) within the VR
group at 12 months.
Conclusions The positive correlations and between-group
analyses indicate a positive effect on psychological well-
being associated with completing voice rehabilitation.
Results highlight potential additional benefits of behavioural
voice intervention beyond achieving direct change to voice
function.
Keywords Voice therapy . Speech-language pathology .
Radiotherapy
Introduction
Within head and neck cancer (HNC) research and clinical
management, greater importance is now being placed on un-
derstanding the sequelae impacting patients post cancer treat-
ment. Such information is essential to guide rehabilitation and
optimise patient function, psychological health and quality of
life for improved survivorship care following cancer. Within
the subgroup of patients who present with laryngeal cancer
managed with organ-preservation treatments, the negative im-
pacts of (chemo)radiotherapy [(C)RT] treatment on function,
health-related quality of life (HRQL) and psychological well-
being/distress have been investigated to varied extents.
Regarding impact to voice function and communication
after laryngeal cancer treatment, research indicates that pa-
tients will experience vocal function changes that vary from
mild to severe in nature. Often presenting as a complex dys-
phonia, the voice post (C)RT has been characterised as harsh,
rough, strained and breathy, with glottal fry and altered pitch
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which may remain with the patient long term [1–5]. Patients
themselves report poor vocal quality, hoarseness, reduced vol-
ume and vocal fatigue following laryngeal cancer treatment
[6–9].
Many studies have also investigated (HRQL) and glob-
al quality of life (QOL) outcomes post laryngeal cancer.
Research specific to non-surgical treatment outcomes in-
dicates that the majority of HRQL (function and symptom
scales) deteriorate 1 month post radiotherapy then improve
6–12 months to reach baseline levels (pre-radiotherapy),
although these remain below normative values [1, 10].
Most HRQL function and symptom outcomes present at
12 months continue to persist long term, up to 5 years post
radiotherapy [11].
However, whilst the impact on functional outcomes and
quality of life has been well explored, research into patient
psychological well-being/distress post laryngeal cancer has
been examined to a lesser extent. Studies suggest that up to
41% of patients experience possible/probable anxiety or de-
pression [12] which may be most prevalent either pre-
radiotherapy [10] or 12 months post [13] and continues to
persist years after management [14]. Johansson and col-
leagues (2011) also identified that patients’mental adjustment
to laryngeal cancer and their coping strategies significantly
impact anxiety, depression, HRQL and survival [15].
Given the extent of functional impairments and reduced qual-
ity of life outcomes after laryngeal cancer treatment, recent re-
search has explored potential benefits of behavioural voice reha-
bilitation for this clinical group. Studies indicate that voice reha-
bilitation post laryngeal cancer significantly improves voice
(acoustic and perceptual qualities), patient perceptions, commu-
nication and several HRQL outcomes when compared to a la-
ryngeal cancer cohort who did not receive voice rehabilitation [9,
16–19]. Furthermore, there is a known interrelationship between
function, quality of life and patient well-being. Rinkel and col-
leagues (2014) highlighted that, specifically within the laryngeal
cancer population, the prevalence of voice, communication (and
swallowing) problems after laryngeal cancer treatment is high
and clearly related to quality of life and emotional distress [20].
Consequently, it could be hypothesised that patients who receive
rehabilitation for their voice deficits following laryngeal cancer,
and experience positive functional and HRQL effects, may also
experience positive benefits for their psychological well-being.
However, whilst results from rehabilitation trials have dem-
onstrated improved voice function and positive impacts to
HRQL outcomes, to date, any potential impact on psycholog-
ical well-being has not been examined. Given the interrela-
tionship between function, HRQL and psychological well-be-
ing, this study aims to determine if there is also an associated
effect on patient well-being/distress, specifically experiences
of anxiety and/or depression for patients who receive behav-




The current data were collected as part of a larger, prospective
randomised control trial at Sahlgrenska University Hospital,
Gothenburg, Sweden [18, 19]. Ethical approval was granted
and the study was conducted in accordance with the
Declaration of Helsinki. Patients diagnosed with laryngeal
cancer (Tis-T4) in the Västra Götaland Region were referred
to a weekly tumour conference at the Otorhinolaryngology
Department and invited to be part of the study. Inclusion
criteria for the study were laryngeal cancer patients planned
for curative (chemo)radiotherapy, who had sufficient Swedish
language competency to independently answer questionnaires
and partake in voice rehabilitation. Exclusion criteria were
tracheostomy and severe cognitive impairment limiting par-
ticipation in voice rehabilitative exercises. A total of 163 pa-
tients were available for inclusion, of which 89 agreed to par-
ticipate or remained eligible for study participation
(CONSORT flow diagram, Fig. 1). Randomisation occurred
electronically using Pocock’s sequential randomisation meth-
od [21] considering patient’s age, smoking status, tumour site,
size and self-evaluation of communication pre (C)RT.
Twenty-six patients were lost to follow-up, leaving a total of
63 patients available for analyses. Comparisons of the demo-
graphics between the two groups confirmed there were no
significant differences between the voice rehabilitation (VR)
and control groups when compared for gender, mean age,
tumour location, radiotherapy regime, comorbidity or work-
ing status (Table 1).
Oncologic treatment
The radiotherapy regime, as determined by regional guide-
lines, was either (1) conventional, once daily radiotherapy at
2–2.4 Gy fractions to a total of 62.4–68 Gy, or (2)
hyperfractionated, twice daily radiotherapy at 1.7 Gy fractions
to a total of 64.6 Gy. Patients with T2–T4 tumours generally
received radiation to lymph nodes (n = 24) and three patients
with T3–T4 tumours also received induction chemotherapy.
Procedure
Outcome assessments occurred at baseline, i.e., 1 month post
(chemo)radiotherapy cessation (pre-voice rehabilitation), and
post voice rehabilitation at 6 and at 12 months post (C)RT. At
each time point, all patients completed an assessment battery
including voice recording and analyses, self-reported communi-
cation experiences and health-related quality of life measures.
These results have been previously reported [9, 18, 19]. For the
current study, only the data relating to patient perceptions of their
voice acceptability and the data relating to patient well-being, as
Support Care Cancer
reported by the Hospital Anxiety and Depression Scale [22], is
examined. The Hospital Anxiety and Depression Scale (HADS)
was developed for the general medical patient population and has
been used extensively both clinically and within research [23]. It
consists of the two scales, anxiety and depression, each with
seven questions answered on a 0–3 scale, where a larger number
represents greater symptoms of anxiety/depression. Within each
scale, summated scores of <8 indicate no case of anxiety/depres-
sion, scores of 8–10 indicate possible anxiety/depression and
scores ≥11 indicate probable anxiety/depression [22]. Patient’s
voice perceptions were examined using a study-specific ques-
tionnaire, reported in earlier studies [9, 24, 25]. However, from
this, only the question examining whether the patient believed
their voice to be acceptable in a social environment, answered on
a Likert scale with 0 = never, 1 = sometimes, 2 = often and 3 =
always, was included in this study.
Voice rehabilitation occurred between pre-voice rehabilita-
tion (1 month post treatment) and the 6-month post (C)RT
time point. Voice rehabilitation consisted of 10 speech pathol-
ogy intervention sessions over 10 weeks using a structured
protocol consisting of both direct and indirect voice interven-
tion, including tasks such as breathing, relaxing, posture and
specific physiology-targeted phonation exercises [9]. The fi-
nal sessions focused on transferability of skills and generali-
sation into conversation and holistic communication. The con-
trol group received general voice education such as vocal
hygiene advice, but not specific intervention.
Statistical methods
Descriptive statistics were used to calculate the proportion of
HADS ‘no case’ versus ‘possible/probable’ anxiety and






Lost to follow-up (n=16)
- Tracheostomised (n=2)
- Discontinued participation (n=8)
- Data collection missed (n=6)
Lost to follow-up (n=10)
- Discontinued participation (n=2)
- Data collection missed (n=8)
























- Declined to participate (n=72)
- Participation in other studies (n=8)
- Poor general health (n=18)
- None stated (n=46)
- Missed before radiotherapy (n=2)




depression. Within- and between-group statistical analyses
were conducted using SPSS statistics software, version 22,
with a significance set at p < 0.05. Within-group analysis
(across time points) was calculated using the McNemar chi-
square test for categorical data. Difference between groups
was calculated using the chi-square statistic. Correlation be-
tween possible/probable anxiety or depression (dichotomous
variable) and patient voice perceptions (ordinal data) was cal-
culated using point-biserial correlation coefficient (rpb) using
VassarStats: Website for Statistical Computation [26].
Correlation strength was interpreted using the following
criteria: 0.00–0.30 = negligible correlation, 0.30–0.50 = low
correlation, 0.50–0.70 = moderate correlation, 0.70–0.90 =
high correlation and 0.90–1.00 = very high correlation [27].
Results
Within- and between-group comparisons are displayed in
Table 2. Within-group analysis showed a trend (p = 0.06), in
the VR group, towards a reduction in number of possible/
probable anxiety cases at 6 months, and by 12 months, the
number of possible/probable anxiety cases was significantly
lower (p = 0.03) than pre-voice rehabilitation. No significant
change in cases of depression, in the VR group, was observed
over time. For the control group, no changes were observed in
the proportion of patients reporting anxiety or depression
across any of the time points.
Between-group analyses revealed no significant difference
between groups at baseline; however, at 6 months, the VR group
reported less cases of possible/probable anxiety and depression, a
difference approaching significance (p = 0.06 and p = 0.08, re-
spectively). By 12 months, however, the two groups were statis-
tically significantly different (p = 0.04) with the VR group
reporting significantly less cases of anxiety and depression than
the controls. Within the VR group at 12 months, significant
correlations were found between positive patient perceptions of
voice acceptability and the reduction in cases of anxiety
(p = 0.03, rpb = −0.38) and depression (p < 0.001, rpb = −0.66).
Discussion
Results from the current study suggest associated positive
effects on psychological well-being following voice rehabili-
tation. At baseline (post radiotherapy/pre-voice rehabilita-
tion), both the control and VR groups were statistically similar
in their reported cases of anxiety/depression, and results from
this study are largely comparable to prior research which in-
dicates that 15 and 23% of patients report anxiety and depres-
sion (respectively), immediately post radiotherapy [13].
Following voice rehabilitation, our results demonstrate that
there was a continued reduction in the proportion of patients
with anxiety between baseline—6 months—and between 6
and 12 months within the VR group only. By 12 months, the
proportion of anxiety (6%) and depression (6%) cases in the
VR group were significantly lower than the control group
where 25% continued to report ongoing anxiety or depression.
The control group data in the current study is largely compa-
rable to previous literature. Hammerlid et al. (1998) found 26
and 24% of their patients indicated anxiety and depression
(respectively) at 12 months [13] whilst, similarly, results from
a cross sectional study reported that 32 and 25% of patients
reported anxiety and depression (respectively) post laryngeal
cancer treatment [12]. Johansson et al. (2008), however, pre-
sented comparatively lower anxiety and depression figures at
12 months [10]. These data from previous studies are gener-
ally congruent with this study’s control group’s proportions of
anxiety and depression and further support the observations
that our VR group presents with lower cases of anxiety and
depression than typically reported for this population,
12 months post (C)RT.
A number of possible theories could be proposed for why
there were improved cases of anxiety and depression follow-
ing voice rehabilitation. One possible reason could be the
improved functional outcomes achieved by voice










Male 28 (87) 27 (87)
Female 4 (13) 4 (13)
Mean age (years) 62.1 65.8 0.19
Range 41–82 41–86
Tumour location 0.59











Conventional 23 (72) 19 (61)
Hyperfractionated 9 (28) 12 (39)
Comorbidity (ACE-27)a (n = 31)b 0.22
None 13 = (42) 13 = (42)
Mild 14 = (45) 9 = (29)
Moderate 4 = (13) 9 = (29)
Severe 0 0
Working status—employed 14 (44) 12 (39) 0.69
Vocally demanding workc 7/14 (50) 7/12 (58) 0.95
a Adult Comorbidity Evaluation (ACE-27) [35]
b One patient with missing data






























































































































































































































































































































































































































rehabilitation. Prior studies have reported positive voice func-
tion (acoustic and perceptual) outcomes following voice reha-
bilitation compared to no voice rehabilitation [9, 16].
Furthermore, Karlsson and colleagues (2015) demonstrated
that voice rehabilitation significantly improved communica-
tion, social function, social contact and quality of life at
6 months post rehabilitation when compared to a control
group [19]. Indeed, in the current study, positive perceptions
of voice acceptability were significantly correlated with fewer
cases of anxiety and depression. This interrelationship and
impact of function on quality of life and psychological well-
being/distress is not a new phenomenon and has been reported
both in the laryngeal cancer population [20] in the larger HNC
population [28, 29].
However, it should be noted that the correlations between
voice acceptability (the patient perceptions of voice function)
and anxiety/depression were small to moderate in size. As
such, additional factors contributing to the positive benefits
observed for the VR group, such as broader impacts of be-
havioural intervention, should be considered. Within HNC
trials, it has been observed that those trials which focus on
improving function, as well as effective communication,
problem-solving, and distress, result in reduced social im-
pairment, psychological distress and improved HRQL [30].
Given that our study’s intervention arm focused on improv-
ing voice function, facilitating effective communication and
transferring skills into the patient specific communication/
social environment, it is possible that an improvement in
these functional skills positively affected quality of life and
patient well-being outcomes, secondary to the interrelation
between these parameters.
The current data raises some important clinical implica-
tions. Function rehabilitation post laryngeal cancer treatment
has shown to improve communication and HRQL outcomes
[9, 16, 18, 19] and, now, the current data supports potential
positive benefits for patient well-being/distress. Furthermore,
it is recognised more broadly in the literature that survivorship
care should incorporate both function rehabilitation and psy-
chosocial intervention [28, 31–33]. Recent research within
HNC literature, investigating behavioural and psychosocial
intervention post treatment, suggests that structured, theoreti-
cally based interventions which address functional, HRQL
and psychosocial impairments and incorporate problem-fo-
cused, self-management, collaborative goal-setting, action-
planning, shared care and linkage to health-care supports are
key elements for survivorship care [31–33]. Although the cur-
rent voice rehabilitation program used in this RCT was not
developed with this specific focus, it has achieved some of
these desired benefits. Future development of behavioural in-
terventions for the laryngeal cancer population need to ensure
that rehabilitation is sufficiently holistic to support the patient
in their recovery, focusing on both function rehabilitation and
psychosocial management.
Limitations of this study include the heterogeneous la-
ryngeal cancer cohort used within this study, including
both glottic and supraglottic tumours and stage I–stage
IV cancers. However, the focus on voice rehabilitation
within the laryngeal cancer population specifically versus
the larger HNC population is also considered to be a
strength of this study. Furthermore, our study’s cohort is
reflective of the usual laryngeal cancer demographics [34];
therefore, results from this study may be generalisable to
the larger laryngeal cancer patient population. It is ac-
knowledged that no data on patient coping skills, adjust-
ment, or other reasons for the observed levels of anxiety or
depression were examined. As such, it is possible that
other factors, unrelated to the voice rehabilitation, could
account for the current findings. Investigation and incor-
poration of these factors are recommended for future
trials.
Conclusion
Although voice rehabilitation has shown to improve function-
al outcomes and positively impact HRQL, the current data
suggests positive associated effects of behavioural voice inter-
vention on psychological distress/well-being. This study
found lower rates of possible/probable anxiety and depression
being reported at 6 and 12 months in the VR group compared
to controls, and this improvement in anxiety/depression cor-
related moderately with patient perceptions of voice accept-
ability. Results highlight potential additional benefits of be-
havioural voice intervention beyond achieving direct change
to voice function.
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